You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
CRO板塊集體大升,藥明康德A股一度升停,2大關鍵事件重點關注
港A兩地CRO板塊集體大升,其中,藥明康德A股一度觸及升停,半日收升8.32%,H股一度升超15%,港股藥明生物升超12%。據路透消息,美國總統拜登上週簽署了一項行政命令,可能會限制基因公司在美國的活動,但同時減輕美國國會民主黨人支持針對中國合同研發和製造企業(如藥明康德和藥明生物)的立法的壓力。另外,美國參議院計劃在2024年3月6日舉行聽證會,討論一項法案,該法案旨在禁止美國聯邦政府機構與中國的華大基因、藥明康德以及其他生物技術公司簽訂合同。有市場人士指出,今日CRO板塊的集體大升,是在提前博弈美國聽證會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account